Short Course Glucocorticoid Treatment for PTSD
A Placebo-controlled, Randomized, Double-blind Comparison of Placebo vs Short Course Low Dose Corticosteroids on Posttraumatic Stress Disorder (PTSD)
Sponsor: University of Wisconsin, Madison
Listed as NCT00204737, this PHASE4 trial focuses on Post-traumatic Stress Disorder and remains completed. Sponsored by University of Wisconsin, Madison, it has been updated 11 times since 2004, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE4
-
Mar 2022 — Dec 2022 [monthly]
Completed PHASE4
▶ Show 6 earlier versions
-
Jan 2022 — Mar 2022 [monthly]
Completed PHASE4
-
Jan 2021 — Jan 2022 [monthly]
Completed PHASE4
-
Jun 2020 — Jan 2021 [monthly]
Completed PHASE4
Phase: NA → PHASE4
-
Jul 2018 — Jun 2020 [monthly]
Completed NA
-
Jun 2018 — Jul 2018 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Dec 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Wisconsin, Madison
For direct contact, visit the study record on ClinicalTrials.gov .